Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients

被引：0
|
作者：
Alain Mina
Hind Rafei
Maya Khalil
Yasmine Hassoun
Zeina Nasser
Arafat Tfayli
机构：
[1] American University of Beirut,Department of Internal Medicine
[2] Internal Medicine Resident-University of Miami Miller School of Medicine-Palm Beach Regional Campus,Department of Internal Medicine
[3] American University of Beirut Medical Center,Faculty of Public Health
[4] Free University of Brussels,undefined
来源：
BMC Cancer | / 15卷
关键词：
Breast cancer; Echocardiography; Anthracycline;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Longitudinal rotation: a new way to detect the cardiotoxicity of anthracycline-based chemotherapy in breast cancer patients
    Huang, Jun
    Yan, Zi-Ning
    Rui, Yi-Fei
    Shen, Dan
    Fan, Li
    Chen, Dong-Liang
    ONCOTARGET, 2017, 8 (41) : 70072 - 70083
  • [32] Late cardiotoxicity in patients with breast cancer after taxane/anthracycline-based neoadjuvant and adjuvant chemotherapy
    Koroleva, I.
    Kopp, M. V.
    Kasulin, A. N.
    Kucheryavyy, J. A.
    Byakhov, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [33] Prediction of trastuzumab-induced cardiotoxicity in breast cancer patients receiving anthracycline-based chemotherapy
    El-Sherbeny, Wafaa S.
    Sabry, Nesreen M.
    Sharbay, Radwa M.
    JOURNAL OF ECHOCARDIOGRAPHY, 2019, 17 (02) : 76 - 83
  • [34] Neutrophil count is not associated with infection episodes in breast cancer patients treated with anthracycline-based chemotherapy
    Mendonca, M. A. O.
    Pereira, A. H. M.
    Silva, S. R.
    Mardegan, M. C.
    Murta, E. F. C.
    Tavares-Murta, B. M.
    EUROPEAN JOURNAL OF CANCER CARE, 2009, 18 (02) : 184 - 190
  • [35] Clinical and echocardiographic characteristics of female patients with breast cancer treated with anthracycline-based combined chemotherapy
    Spannbauer, A.
    Han, E.
    Gramser, A.
    Gyoengyoesi, M.
    Bergler-Klein, J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (SUPPL 2) : 196 - 197
  • [36] Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients
    Isabel Chirivella
    Begoña Bermejo
    Amelia Insa
    Alejandro Pérez-Fidalgo
    Ana Magro
    Susana Rosello
    Elisa García-Garre
    Paloma Martín
    Ana Bosch
    Ana Lluch
    Breast Cancer Research and Treatment, 2009, 114 : 479 - 484
  • [37] Effective Antiemetic Therapy Is Important With Adjuvant Anthracycline-based Chemotherapy in Breast Cancer
    Takala, Laura
    Barlund, Maarit
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Pirkko, Liisa
    ANTICANCER RESEARCH, 2019, 39 (01) : 279 - 283
  • [38] The Double-Edged Sword: Controversies in Anthracycline-Based Chemotherapy for Breast Cancer
    Kota K.J.
    Brufsky A.M.
    Current Breast Cancer Reports, 2017, 9 (4) : 210 - 216
  • [39] HER2 and response to anthracycline-based neoadjuvant chemotherapy in breast cancer
    Yao, L.
    Liu, Y.
    Li, Z.
    Ouyang, T.
    Li, J.
    Wang, T.
    Fan, Z.
    Fan, T.
    Lin, B.
    Xie, Y.
    ANNALS OF ONCOLOGY, 2011, 22 (06) : 1326 - 1331
  • [40] Anthracycline-based Chemotherapy in A Patient with Breast Cancer and Left-Ventricular Hypertrabeculation
    Rahme, Serena Joseph
    Cathcart-Rake, Elizabeth
    Giudicessi, John
    Giudicessi, John
    Herrmann, Joerg
    CIRCULATION, 2024, 150
12345